Delayed antigen presentation by epidermal Langerhans cells to cloned T h1 and T h2 cells.

Langerhans (LC) cells require incubation with protein antigen for several days before the cells effectively stimulate proliferation of cloned, H-2 restricted, antigen-specific T h cells. In contrast, splenic antigen-presenting cells are immediately effective. LC are immediately competent, however, if an immunogenic peptide rather than the intact protein is the immunogen, indicating that resident or unchallenged LC have the required class II MHC and can provide the signals necessary for T-cell proliferation but may lack the capacity to internalize or cleave protein antigens. We propose that delayed antigen presentation by LC may be intrinsic and advantageous for promoting early systemic immunity. LC stimulate cloned T h1 and T h2 cells equally well, suggesting that LC may not limit or bias the type of immunity that occurs with cutaneous antigenic challenge.

[1]  J. Streilein,et al.  In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. , 1989, Journal of immunology.

[2]  J. Bluestone,et al.  T helper 2 (Th2) but not Th1 clones co-stimulate resting T cells in the presence of anti-CD3 monoclonal antibody. , 1989, International immunology.

[3]  B. Evavold,et al.  Production of IL-2 and IFN by TH2 clones. , 1989, Immunology letters.

[4]  R. Steinman,et al.  Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells , 1989, The Journal of experimental medicine.

[5]  L. Matis,et al.  Two distinct mechanisms account for the immune response (Ir) gene control of the T cell response to pigeon cytochrome c. , 1988, Journal of immunology.

[6]  C. Picut,et al.  Immunostimulatory capabilities of highly enriched Langerhans cells in vitro. , 1988, The Journal of investigative dermatology.

[7]  R. Steinman,et al.  Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells , 1987, The Journal of experimental medicine.

[8]  D. Stephany,et al.  Enhanced antigen-presenting capacity of cultured Langerhans' cells is associated with markedly increased expression of Ia antigen. , 1987, Journal of immunology.

[9]  R. Steinman,et al.  Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes , 1986, The Journal of experimental medicine.

[10]  R. Schwartz,et al.  Functional analysis of the interaction of the antigen-specific T cell receptor with its ligands. , 1986, Journal of immunology.

[11]  R. Schwartz,et al.  The T lymphocyte response to cytochrome c. V. Determination of the minimal peptide size required for stimulation of T cell clones and assessment of the contribution of each residue beyond this size to antigenic potency. , 1985, Journal of immunology.

[12]  J. Streilein,et al.  FACS purification of bone marrow-derived epidermal populations in mice: Langerhans cells and Thy-1+ dendritic cells. , 1985, The Journal of investigative dermatology.

[13]  L. Samelson An analysis of the structure of the antigen receptor on a pigeon cytochrome c-specific T cell hybrid. , 1985, Journal of immunology.

[14]  R. Steinman,et al.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro , 1985, The Journal of experimental medicine.

[15]  R. Atkins,et al.  THE SPECIFIC SELECTION OF RECIRCULATING LYMPHOCYTES BY ANTIGEN IN NORMAL AND PREIMMUNIZED RATS , 1972, The Journal of experimental medicine.

[16]  J. Sprent,et al.  Antigen-induced selective recruitment of circulating lymphocytes. , 1971, Cellular immunology.